These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7846113)

  • 1. Vascular targeting--a new approach to the therapy of solid tumors.
    Burrows FJ; Thorpe PE
    Pharmacol Ther; 1994 Oct; 64(1):155-74. PubMed ID: 7846113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-directed targeting of the vasculature of solid tumors.
    Thorpe PE; Burrows FJ
    Breast Cancer Res Treat; 1995; 36(2):237-51. PubMed ID: 8534871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress on tumor missile therapy and tumor vascular targeting therapy as a new approach.
    Yoshioka Y; Tsutsumi Y; Nakagawa S; Mayumi T
    Curr Vasc Pharmacol; 2004 Jul; 2(3):259-70. PubMed ID: 15320824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies.
    Dvorak HF; Nagy JA; Dvorak AM
    Cancer Cells; 1991 Mar; 3(3):77-85. PubMed ID: 1711364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoconjugates and immunotoxins for therapy of solid tumors.
    Hellström I; Trail P; Siegall C; Firestone R; Hellström KE
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S35-6. PubMed ID: 8765413
    [No Abstract]   [Full Text] [Related]  

  • 6. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature.
    Burrows FJ; Thorpe PE
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8996-9000. PubMed ID: 7692443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor as a marker of tumor endothelium.
    Brekken RA; Huang X; King SW; Thorpe PE
    Cancer Res; 1998 May; 58(9):1952-9. PubMed ID: 9581838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
    Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
    Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent antitumor effects of an antitumor endothelial cell immunotoxin in a murine vascular targeting model.
    Burrows FJ; Overholser JP; Thorpe PE
    Cell Biophys; 1994; 24-25():15-25. PubMed ID: 7736519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors.
    Burrows FJ; Watanabe Y; Thorpe PE
    Cancer Res; 1992 Nov; 52(21):5954-62. PubMed ID: 1394221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].
    Chiron MF
    Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor--immunotoxin target gene.
    Jin N; Chen W; Blazar BR; Ramakrishnan S; Vallera DA
    Hum Gene Ther; 2002 Mar; 13(4):497-508. PubMed ID: 11874628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of monoclonal antibodies in the immunotherapy of neoplasms].
    Robak T
    Przegl Lek; 1989; 46(4):420-6. PubMed ID: 2672121
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies.
    Matsuno F; Haruta Y; Kondo M; Tsai H; Barcos M; Seon BK
    Clin Cancer Res; 1999 Feb; 5(2):371-82. PubMed ID: 10037187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-based targeting of the tumor vasculature.
    Schliemann C; Neri D
    Biochim Biophys Acta; 2007 Dec; 1776(2):175-92. PubMed ID: 17920773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a monoclonal antibody, TV-1, directed against the basement membrane of tumor vessels, and its use to enhance the delivery of macromolecules to tumors after conjugation with interleukin 2.
    Epstein AL; Khawli LA; Hornick JL; Taylor CR
    Cancer Res; 1995 Jun; 55(12):2673-80. PubMed ID: 7780984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and vascular targeting of solid tumors.
    Brekken RA; Thorpe PE
    Anticancer Res; 2001; 21(6B):4221-9. PubMed ID: 11908675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxins against solid tumors.
    Pirker R
    J Cancer Res Clin Oncol; 1988; 114(4):385-93. PubMed ID: 3045130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the vasculature of solid tumours.
    Murray JC; Hewett PW; Martin SG
    QJM; 1996 Mar; 89(3):165-7. PubMed ID: 8731559
    [No Abstract]   [Full Text] [Related]  

  • 20. VEGF as a mediator of tumor-associated immunodeficiency.
    Ohm JE; Carbone DP
    Immunol Res; 2001; 23(2-3):263-72. PubMed ID: 11444391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.